Showing results (31-40 of 85) with videos related to
Sort By:
Pageof 9
The Neurologist|February 19, 2015
Interictal regional delta slowing in cerebral sinus vein thrombosisSharon Aharoni, Hadassa Goldberg-Stern, Liora Kornreich, et al.HLA|July 5, 2019
Identification of the novel HLA-B allele, HLA-B*15:539, in a South-Sudanese individualGil Benedek, Mahmoud Abed El-Latif, Keren Miller, et al.Journal of Child Neurology|March 2, 2012
Effect of melatonin on seizure frequency in intractable epilepsy: a pilot studyHadassa Goldberg-Stern, Heftsiba Oren, Nir Peled, et al.European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|August 21, 2014
Endocrine effects of valproic acid therapy in girls with epilepsy: a prospective studyHadassa Goldberg-Stern, Eyal Yaacobi, Moshe Phillip, et al.Hormone Research in Paediatrics|March 21, 2015
Endocrine Effects of Valproate versus Carbamazepine in Males with Epilepsy: A Prospective StudyHadassa Goldberg-Stern, Tomer Itzhaki, Zohar Landau, et al.Experimental Neurology|May 24, 2005
Immunization with the glutamate receptor-derived peptide GluR3B induces neuronal death and reactive gliosis, but confers partial protection from pentylenetetrazole-induced seizuresYonatan Ganor, Miroslav Gottlieb, Raya Eilam, et al.Nature Medicine|November 26, 2002
The neuropeptides GnRH-II and GnRH-I are produced by human T cells and trigger laminin receptor gene expression, adhesion, chemotaxis and homing to specific organsAlon Chen, Yonatan Ganor, Shai Rahimipour, et al.Leukemia & Lymphoma|April 25, 2009
Human T-leukemia and T-lymphoma express glutamate receptor AMPA GluR3, and the neurotransmitter glutamate elevates the cancer-related matrix-metalloproteinases inducer CD147/EMMPRIN, MMP-9 secretion and engraftment of T-leukemia in vivoYonatan Ganor, Igor Grinberg, Arbel Reis, et al.Human Reproduction (Oxford, England)|December 19, 2006
GnRH agonist treatment in girls with precocious puberty does not compromise post-pubertal uterine sizeAvi Ben-Haroush, Hadassa Goldberg-Stern, Moshe Phillip, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|July 18, 2014
Towards neuroimmunotherapy for cancer: the neurotransmitters glutamate, dopamine and GnRH-II augment substantially the ability of T cells of few head and neck cancer patients to perform spontaneous migration, chemotactic migration and migration towards the autologous tumor, and also elevate markedly the expression of CD3zeta and CD3epsilon TCR-associated chainsSven Saussez, Barbara Laumbacher, Gilbert Chantrain, et al.Pageof 9